John F Crowley is Executive Chairman of AMICUS THERAPEUTICS, INC.. Currently has a direct ownership of 573,478 shares of FOLD, which is worth approximately $3.92 Million. The most recent transaction as insider was on Jun 15, 2023, when has been sold 6,044 shares (Common Stock) at a price of $13.04 per share, resulting in proceeds of $78,813. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 573K
0% 3M change
0% 12M change
Total Value Held $3.92 Million

John F Crowley Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 15 2023
SELL
Open market or private sale
$78,813 $13.04 p/Share
6,044 Reduced 0.63%
950,273 Common Stock
Jun 01 2023
SELL
Open market or private sale
$68,659 $11.36 p/Share
6,044 Reduced 0.63%
956,317 Common Stock
May 15 2023
SELL
Open market or private sale
$67,571 $11.18 p/Share
6,044 Reduced 0.62%
962,361 Common Stock
May 01 2023
SELL
Open market or private sale
$71,319 $11.8 p/Share
6,044 Reduced 0.62%
968,405 Common Stock
Apr 17 2023
SELL
Open market or private sale
$70,473 $11.66 p/Share
6,044 Reduced 0.62%
974,449 Common Stock
Apr 03 2023
SELL
Open market or private sale
$67,813 $11.22 p/Share
6,044 Reduced 0.61%
980,493 Common Stock
Mar 15 2023
SELL
Open market or private sale
$68,538 $11.34 p/Share
6,044 Reduced 0.61%
986,537 Common Stock
Mar 01 2023
SELL
Open market or private sale
$81,533 $13.49 p/Share
6,044 Reduced 0.61%
992,581 Common Stock
Feb 15 2023
SELL
Open market or private sale
$78,209 $12.94 p/Share
6,044 Reduced 0.6%
998,625 Common Stock
Feb 01 2023
SELL
Open market or private sale
$1,931,312 $13.11 p/Share
147,316 Reduced 12.79%
1,004,669 Common Stock
Feb 01 2023
BUY
Exercise of conversion of derivative security
$786,400 $5.62 p/Share
139,929 Added 10.83%
1,151,985 Common Stock
Jan 11 2023
SELL
Payment of exercise price or tax liability
$1,000,797 $12.02 p/Share
83,261 Reduced 7.6%
1,012,056 Common Stock
Jan 11 2023
BUY
Grant, award, or other acquisition
-
210,088 Added 16.09%
1,095,317 Common Stock
Jan 09 2023
SELL
Open market or private sale
$972,715 $11.43 p/Share
85,102 Reduced 8.77%
885,229 Common Stock
Jan 04 2023
SELL
Payment of exercise price or tax liability
$128,227 $12.03 p/Share
10,659 Reduced 1.09%
970,331 Common Stock
Jan 03 2023
SELL
Payment of exercise price or tax liability
$263,843 $11.93 p/Share
22,116 Reduced 2.87%
747,742 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
233,248 Added 19.21%
980,990 Common Stock
Jan 02 2023
SELL
Payment of exercise price or tax liability
$263,687 $12.21 p/Share
21,596 Reduced 2.73%
769,858 Common Stock
Dec 15 2022
SELL
Open market or private sale
$127,186 $12.15 p/Share
10,468 Reduced 1.31%
791,454 Common Stock
Dec 01 2022
SELL
Open market or private sale
$138,433 $12.2 p/Share
11,347 Reduced 1.4%
801,922 Common Stock
Nov 15 2022
SELL
Open market or private sale
$121,847 $11.64 p/Share
10,468 Reduced 1.27%
813,269 Common Stock
Nov 01 2022
SELL
Open market or private sale
$117,090 $10.32 p/Share
11,346 Reduced 1.36%
823,737 Common Stock
Oct 17 2022
SELL
Open market or private sale
$114,101 $10.9 p/Share
10,468 Reduced 1.24%
835,083 Common Stock
Oct 03 2022
SELL
Open market or private sale
$121,970 $10.75 p/Share
11,346 Reduced 1.32%
845,551 Common Stock
Sep 15 2022
SELL
Open market or private sale
$111,589 $10.66 p/Share
10,468 Reduced 1.21%
856,897 Common Stock

Also insider at

NTLA
Intellia Therapeutics, Inc. Healthcare
TRDA
Entrada Therapeutics, Inc. Healthcare
JFC

John F Crowley

Executive Chairman
Boston, MA

Track Institutional and Insider Activities on FOLD

Follow AMICUS THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FOLD shares.

Notify only if

Insider Trading

Get notified when an Amicus Therapeutics, Inc. insider buys or sells FOLD shares.

Notify only if

News

Receive news related to AMICUS THERAPEUTICS, INC.

Track Activities on FOLD